Scholar Rock Holding (SRRK) Operating Margin (2019 - 2022)
Scholar Rock Holding (SRRK) posted quarterly Operating Margin of 20.89% for Q1 2022, up 55700.0% year-over-year from N/an in Q1 2021, and up 97.61% quarter-over-quarter from 873.4% in Q4 2021.
Scholar Rock Holding (SRRK) Operating Margin (2019 - 2022) Analysis & Trends
Scholar Rock Holding's Operating Margin history runs 4 years deep, the most recent figure standing at 20.89% for Q1 2022.
- In Q1 2022, Operating Margin rose 55700.0% year-over-year to 20.89%; the TTM figure through Dec 2022 stood at 404.81% (up 28567.0% YoY), while the FY2022 annual figure was 404.81%, up 28567.0% from the prior year.
- Operating Margin for Q1 2022 stood at 20.89%, up from 873.4% in the prior quarter.
- The five-year high for Operating Margin was 20.89% in Q1 2022, with the low at 873.4% in Q4 2021.
- The 4-year median for Operating Margin is 499.03% (2020), against an average of 489.35%.
- The sharpest annual moves came in 2020 and 2022: Operating Margin plunged 59668 bps in 2020, then soared 55700 bps in 2022.
- Scholar Rock Holding's Operating Margin stood at 163.04% in 2019, then tumbled by 366 bps to 759.72% in 2020, then slipped by 15 bps to 873.4% in 2021, then jumped by 98 bps to 20.89% in 2022.
- Business Quant data shows SRRK's Operating Margin at 20.89% in Q1 2022, 873.4% in Q4 2021, and 678.57% in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -105.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Scholar Rock Holding | 6.39 Bn | 6.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -20.89% |
| Dec 31, 2021 | -873.40% |
| Sep 30, 2021 | -678.57% |
| Jun 30, 2021 | -658.82% |
| Mar 31, 2021 | -577.89% |
| Dec 31, 2020 | -759.72% |
| Sep 30, 2020 | -777.68% |
| Jun 30, 2020 | -499.03% |
| Mar 31, 2020 | -351.77% |
| Dec 31, 2019 | -163.04% |
| Sep 30, 2019 | -358.32% |
| Jun 30, 2019 | -265.65% |
| Mar 31, 2019 | -376.79% |